Latest news
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alphatec Holdings (ATEC), Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) - theglobeandmail.comtheglobeandmail.com · Thu, 06 Aug 2026 09:38:49 GMTVRTX Maintained by Truist Securities -- Price Target Raised to $565 - GuruFocusGuruFocus · Wed, 05 Aug 2026 19:43:53 GMTMaxim Group Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $575 - MoomooMoomoo · Wed, 05 Aug 2026 19:07:34 GMTVRTX Maintained by Barclays -- Price Target Raised to $617.00 - GuruFocusGuruFocus · Wed, 05 Aug 2026 15:55:37 GMTVertex Pharmaceuticals Faces New Competitive Threats - Intellectia AIIntellectia AI · Wed, 05 Aug 2026 07:00:00 GMTVRTX Maintained by TD Cowen -- Price Target Raised to $550 - GuruFocusGuruFocus · Tue, 04 Aug 2026 20:10:51 GMTVRTX Maintained by Canaccord Genuity -- Price Target Raised to $442 - GuruFocusGuruFocus · Tue, 04 Aug 2026 16:35:09 GMTVRTX Maintained by Cantor Fitzgerald -- Price Target Raised to $595 - GuruFocusGuruFocus · Tue, 04 Aug 2026 15:10:37 GMT